A detailed history of Prossimo Advisors, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Prossimo Advisors, LLC holds 9,472 shares of NVO stock, worth $1.02 Million. This represents 0.82% of its overall portfolio holdings.

Number of Shares
9,472
Previous 9,330 1.52%
Holding current value
$1.02 Million
Previous $1.33 Million 15.32%
% of portfolio
0.82%
Previous 1.21%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

BUY
$119.07 - $145.42 $16,907 - $20,649
142 Added 1.52%
9,472 $1.13 Million
Q2 2024

Jul 22, 2024

BUY
$122.71 - $146.91 $1.14 Million - $1.37 Million
9,330 New
9,330 $1.33 Million
Q2 2023

Jul 24, 2023

BUY
$155.98 - $172.65 $352,514 - $390,189
2,260 New
2,260 $366,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $242B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Prossimo Advisors, LLC Portfolio

Follow Prossimo Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prossimo Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prossimo Advisors, LLC with notifications on news.